Treatment Outcome
"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 26 | 26 | | 1997 | 0 | 44 | 44 | | 1998 | 0 | 53 | 53 | | 1999 | 1 | 41 | 42 | | 2000 | 0 | 65 | 65 | | 2001 | 0 | 72 | 72 | | 2002 | 1 | 75 | 76 | | 2003 | 1 | 123 | 124 | | 2004 | 2 | 135 | 137 | | 2005 | 4 | 173 | 177 | | 2006 | 1 | 198 | 199 | | 2007 | 2 | 201 | 203 | | 2008 | 1 | 237 | 238 | | 2009 | 3 | 264 | 267 | | 2010 | 2 | 304 | 306 | | 2011 | 1 | 346 | 347 | | 2012 | 0 | 345 | 345 | | 2013 | 3 | 412 | 415 | | 2014 | 4 | 451 | 455 | | 2015 | 1 | 447 | 448 | | 2016 | 1 | 424 | 425 | | 2017 | 5 | 532 | 537 | | 2018 | 5 | 522 | 527 | | 2019 | 5 | 487 | 492 | | 2020 | 3 | 468 | 471 | | 2021 | 4 | 397 | 401 | | 2022 | 0 | 385 | 385 | | 2023 | 0 | 317 | 317 | | 2024 | 0 | 471 | 471 | | 2025 | 0 | 482 | 482 | | 2026 | 0 | 231 | 231 |
To return to the timeline, click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Locatelli F, Karakukcu M, Huynh V, González-Martínez B, Lins MM, Lu MY, Sulis ML, Pauly M, Morris C, Braunlin M, Talpes M, Gore L. Carfilzomib plus induction chemotherapy for children with relapsed or refractory acute lymphoblastic leukemia. Blood Adv. 2026 Oct 13; 10(19):6567-6577.
-
Callen AL, Montes D, Amrhein TJ, Beck J, Barvulsky E, Bhaumik D, Boyke AE, Cagnazzo F, Carlton Jones L, Dobrocky T, Kranz PG, Lennarson P, Madhavan A, Mamlouk MD, Mark IT, Maya M, Piechowiak EI, Schievink W, Volz F, Wolf K, Urbach H, Lützen N. Sacral Dural Tears in Spontaneous Intracranial Hypotension: Imaging Phenotype and Treatment Outcomes in a Multicenter Cohort. AJNR Am J Neuroradiol. 2026 Oct 01; 47(10):2674-2681.
-
Evageliou NF, Renfro LA, Vallance KL, Varela CR, Benedetti DJ, Cost NG, Ehrlich PF, Kalapurakal JA, Khanna G, Aldrink JH, Glick RD, Ortiz MV, Parsons LN, Paulino AC, Artunduaga M, Smith EA, Dix DB, Fernandez CV, Dome JS, Geller JI, Mullen EA. Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children's Oncology Group AREN0532, AREN0533, and AREN03B2 studies. Cancer. 2026 Oct 01; 132(19):e70610.
-
Wang Z, Ruseckaite R, Dobric A, Li D, Liu Z, Wark P, Schultz A, Felton I, Bentley S, Davies J, Duckers J, Middleton PG, Taylor-Cousar JL, Richardson L, Rolnik DL, Menkhorst E, Schneider-Futschik EK. Maternal and fetal outcomes associated with CFTR modulator use during pregnancy: a scoping review. Eur Respir Rev. 2026 Jul; 35(181).
-
Halimi A, Zwart ES, Yilmaz BS, Kurlinkus B, Ahola R, Del Chiaro M, Sparrelid E, Rangelova E, Maggino L, Malleo G, Lionetto G, Salvia R, Roberts KJ, Giovinazzo F, Falconi M, Crippa S, Belfiori G, Kazemier G, Maisonneuve P, Laukkarinen J, Ceyhan GO. Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis. Langenbecks Arch Surg. 2026 Sep 22; 411(1).
-
Paik WH, Huh G, Choi YH, Choi JH, Cho IR, Lee SH, Ryu JK, Kim HJ, Lee T, Park CH, Lee Y, Cho SH, Seo DW, Lee KH, Lee KT, Lee JK, Jang S, Vargo J, Edmundowicz S, Park JK, Park DH. Acetate- Versus Lactate-Buffered Crystalloids for Prevention of Post-ERCP Pancreatitis in Patients Without Access to Rectal NSAIDs: A Multicentre Double-Blind Randomized Trial. United European Gastroenterol J. 2026 Sep; 14(7):e70281.
-
Stacchiotti S, Blay JY, Rutkowski P, Gelderblom H, Falcón A, Le Cesne A, Desai J, Palmerini E, Serrano C, Ganjoo KN, D'Amato GZ, Ryan CW, Wilky BA, Ferraresi V, Saleh R, Ravi V, Razak AA, Herráez AC, Ahmed M, Bernthal NM, van de Sande M, Brahmi M, Szostakowski B, Sen J, Zeringo NA, Harrow B, Narasimhan S, Saunders A, Sharma MG, Sherman ML, Wagner AJ, Tap WD. Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial. Cancer. 2026 Sep 01; 132(17):e70564.
-
Mitchell JJ, Abdenur JE, de Boer F, Boyer M, Breilyn MS, Couce ML, De Leon DD, Derks TG, El-Gharbawy A, Haijer-Schreuder AB, Loechner K, Longo N, Lund AM, Olmos MAM, McCandless SE, de Oliveira BM, Mount M, Muschol N, Pytlak K, Radhakrishnan K, Riba-Wolman R, Rodriguez-Buritica DF, La Rosa A, Rossi A, Saavedra H, Santer R, Shayota B, Smit GPA, Moura De Souza CF, van der Klauw MM, Weinstein DA, Wolfsdorf JI, Blake A, Grimm AA, Mitragotri D, Rahman S, Turner-Bowker DM, Collis R. Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa. J Inherit Metab Dis. 2026 Sep; 49(5):e70241.
-
Paganoni S, Chibnik LB, Quintana M, Macklin EA, Detry MA, Vestrucci M, Paulon G, McGlothlin A, Wang J, Walk D, Elman L, Chase M, Heyd L, Harkey B, Sherman AV, Shefner J, Berry JD, Scirocco E, Giacomelli E, Yu H, Kittle G, Hall M, Ho D, Jawdat O, Ladha S, Locatelli E, Rivner M, Felice K, Katz J, Ajroud-Driss S, Fee D, Miller T, Rosow L, Quick A, Heitzman D, Foster LA, Maragakis NJ, Goutman SA, Rosenfeld J, Benatar M, Swenson A, Connors RD, Shroff S, Bedlack R, McIlduff CE, Chen IA, Fernandes JAM, Walsh A, Peltier A, Ilieva H, Diaz F, Kushlaf H, Beydoun SR, Myers B, Arcila-Londono X, Heiman-Patterson T, Elliott M, Whitesell J, Al-Lahham T, Elliott M, Olney N, Baer M, Jackson C, Young E, Caress J, Weiss MD, Kuenzler R, Nayar S, Kasarskis EJ, Simmons Z, Gibson S, Owegi MA, Goyal NA, Wymer JP, Gwathmey KG, Erickson A, Gursoy N, Alameda G, Bodkin C, Wu A, Martinez-Thompson J, Twydell PT, Andrews J, Bayat E, Rezania K, Usman U, McCluskey L, Kovvuru S, Jennings D, Garza-Meilandt A, Maciuca R, Cohen IV, Tamuly D, Eren E, Cudkowicz ME, Babu S. DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2026 Sep 01; 9(9):e2634809.
-
Chang HY, Fang HY, Huang MS, Chen YZ, Chen DY, Lai EC, Wang JD, Li YH, Ku LE. Outcome evaluation of percutaneous coronary intervention vs medical therapy alone in patients with chronic coronary syndrome. J Food Drug Anal. 2026 Sep 01; 34(3):407-416.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|